These observed differences in the distribution of estrogen receptor-positive subtypes were concordant between gene expression-based classifications and IHC-based classifications, and remain statistically significant after correcting for confounding effects of tumor stage and histology subtype (Supplementary Data 3). The gene discussed is ESR1; the disease is neoplasm.